Hyperinsulinism – Diagnostics – Overview of Information and Clinical Research

Diagnosing hyperinsulinism early can be the difference between healthy development and permanent brain damage. This rare condition, where the pancreas produces too much insulin, causes dangerously low blood sugar levels that can harm the brain if not quickly identified and treated. Understanding when to seek testing and what diagnostic tools are available is essential for parents, caregivers, and healthcare providers working to protect vulnerable infants and children.

Introduction: Who Should Be Tested and When

Hyperinsulinism most commonly affects newborns and infants, though it can appear later in childhood or even adulthood. Anyone experiencing symptoms of low blood sugar should be evaluated, but the need for diagnostic testing becomes especially urgent in certain situations. Newborns who show signs of hypoglycemia—abnormally low blood sugar—within the first hours or days of life need immediate assessment. This includes babies who are unusually sleepy, feeding poorly, appearing cold or lethargic, or showing pale or bluish skin coloring.^[4]

Because low blood sugar symptoms in babies can easily be mistaken for typical newborn behavior, many cases go unrecognized initially. Excessive hunger, irritability, and prolonged sleeping might seem normal, but when combined with other signs, they warrant medical attention. In older children, symptoms become somewhat easier to identify and may include shaking, weakness, confusion, anxiety, or extreme tiredness. If a child experiences these symptoms regularly, especially before meals or after physical activity, diagnostic testing for hyperinsulinism should be considered.^[4]

Certain babies face higher risk and should be monitored closely even without obvious symptoms. Infants who experienced stress during birth—such as oxygen deprivation or problems with the placenta—may develop a temporary form of hyperinsulinism. Babies born to mothers with poorly controlled diabetes during pregnancy are also at increased risk. Additionally, children diagnosed with certain genetic syndromes, including Beckwith-Wiedemann syndrome, Kabuki syndrome, Sotos syndrome, or Turner syndrome, should undergo screening for hyperinsulinism as these conditions frequently occur together.^[4]

⚠️ Important

Blood sugar levels below 60 milligrams per deciliter are considered low, and levels below 50 mg/dL can cause serious symptoms including seizures and coma. Because the brain depends entirely on glucose for fuel, prolonged or severe hypoglycemia can result in permanent brain damage, developmental delays, learning disabilities, and motor problems. This makes early diagnosis absolutely critical for protecting a child’s future.^[4]

If hyperinsulinism runs in your family, genetic counseling and prenatal testing may be recommended. In some cases, the condition can be detected before birth through amniocentesis—a test where a small amount of fluid surrounding the baby in the womb is analyzed. This advance knowledge allows medical teams to prepare for the baby’s arrival and begin treatment immediately after birth, potentially preventing brain injury.^[18]

Classic Diagnostic Methods

Diagnosing hyperinsulinism involves more than simply checking blood sugar levels, though that is where testing typically begins. The diagnosis requires proving that low blood sugar occurs together with inappropriately high insulin levels—a combination that should not happen in a healthy person. When blood sugar drops, insulin production should stop, but in hyperinsulinism, the pancreas continues releasing insulin despite dangerously low glucose levels.^[1]

Blood Tests and Laboratory Analysis

The most important diagnostic step is collecting blood samples when the child’s blood sugar is low. This is called a critical sample, and it must be obtained at the exact moment hypoglycemia occurs because testing blood when glucose levels are normal will not reveal the problem. During a hypoglycemic episode, doctors measure several substances in the blood simultaneously, including glucose, insulin, and ketone bodies. Ketone bodies are alternative fuels the body normally produces when blood sugar is low, but hyperinsulinism blocks their production, leaving the brain without any fuel source at all.^[7]

In hyperinsulinism, the critical sample typically shows blood glucose below 50 mg/dL alongside measurable insulin levels. In a healthy person, insulin should be undetectable when blood sugar is this low. Additional blood tests during hypoglycemia may reveal low levels of fatty acids and ketones, which confirms that excess insulin is preventing the body from accessing its backup energy stores. Some specialized centers also measure C-peptide, a substance released along with insulin, which helps confirm that insulin is being produced by the pancreas itself rather than being injected from an outside source.^[10]

Blood tests alone cannot always distinguish hyperinsulinism from other causes of low blood sugar, so doctors often need to perform additional assessments. They may check hormone levels including cortisol and growth hormone, which help regulate blood sugar. Testing may also include measuring blood ammonia levels, as certain forms of hyperinsulinism cause ammonia to build up. If ammonia is elevated, it suggests a specific genetic type called GDH-HI, where eating protein triggers insulin release and low blood sugar.^[7]

Fasting Studies and Provocative Testing

Many children with hyperinsulinism will be asked to undergo a supervised fasting study in the hospital. This controlled test involves withholding food while continuously monitoring blood sugar and other metabolic markers. The medical team carefully watches for hypoglycemia and immediately obtains critical blood samples when it occurs. Healthy infants can typically fast for six hours—essentially skipping one feeding—without their blood sugar dropping dangerously low. Children with hyperinsulinism, however, cannot maintain normal glucose levels during such a fast.^[6]

The fasting study also helps determine the severity of the condition. Some children develop hypoglycemia within an hour or two of stopping feeding, indicating very severe hyperinsulinism that will likely require aggressive treatment. Others can fast longer before blood sugar drops, suggesting a milder form that might respond to medication. Before a child is discharged from the hospital after diagnosis, doctors typically perform a shorter fasting study lasting six to eight hours to confirm the child can safely tolerate a missed or inadequate feeding at home.^[6]

In older children who can eat regular meals, doctors may use a protein-loading test to diagnose certain forms of hyperinsulinism. The child is given a protein-rich drink or meal, and blood sugar is monitored afterward. In GDH-HI, protein consumption triggers excessive insulin release, causing blood sugar to plummet. This specific response helps identify which genetic mutation is responsible and guides treatment decisions, as children with this form need to follow a low-protein diet.^[9]

Genetic Testing

Genetic testing has become a cornerstone of hyperinsulinism diagnosis, as mutations in at least ten different genes can cause the condition. Identifying the specific genetic cause helps predict how the disease will progress, determines which treatments are most likely to work, and provides information about whether siblings might be affected. Blood samples are sent to specialized laboratories where scientists examine the genes known to regulate insulin secretion from pancreatic beta cells—the cells that produce insulin.^[7]

The most common genetic causes involve mutations in genes called ABCC8 and KCNJ11, which control potassium channels in beta cells. These channels act like gates that open and close to regulate insulin release. When they malfunction, the gates stay closed and insulin pours out continuously regardless of blood sugar levels. Other genetic mutations affect different parts of the insulin-control system. Mutations in the GLUD1 gene cause the protein-triggered form mentioned earlier, while mutations in GCK, HADH, and other genes affect how beta cells sense and respond to nutrients.^[7]

Genetic testing results typically take several weeks to return, but rapid genetic testing is increasingly available at specialized hyperinsulinism centers. Quick results are especially valuable in newborns because the genetic information helps doctors predict whether medication will work or whether surgery will be needed. However, even with advanced testing, about half of hyperinsulinism cases have no identifiable genetic mutation. This suggests additional disease-causing genes remain undiscovered, and research continues to identify them.^[12]

Specialized Imaging Studies

One of the most important advances in hyperinsulinism diagnosis has been the development of specialized imaging to determine whether the entire pancreas is affected (called diffuse disease) or whether only a small area is abnormal (called focal disease). This distinction is critical because focal disease can be completely cured by surgically removing the abnormal section of pancreas, while diffuse disease requires lifelong medical management or removal of most of the pancreas.^[7]

The imaging test used to identify focal lesions is called an 18F-DOPA PET-CT scan. This specialized scan works by injecting a radioactive substance that is specifically taken up by abnormal beta cells. The substance lights up on the scan, showing doctors exactly where in the pancreas the problem area is located. The scan combines positron emission tomography (PET), which shows metabolic activity, with computed tomography (CT), which provides detailed anatomical pictures. Together, they create a roadmap that surgeons can use to remove only the diseased tissue while leaving healthy pancreas behind.^[16]

PET-CT scanning is not universally available and is typically performed only at specialized hyperinsulinism centers. The procedure requires the child to lie still for about 30-60 minutes, so young children usually need sedation or anesthesia. The test involves some radiation exposure, but most experts agree the benefits—potentially curing the disease with limited surgery—far outweigh the small radiation risk. Not all centers have access to this technology, and in some parts of the world, it remains unavailable, making management decisions more difficult.^[16]

Continuous Glucose Monitoring

Traditional blood sugar testing requires pricking the finger or drawing blood from a vein multiple times daily, which is painful and provides only snapshots of glucose levels at specific moments. Continuous glucose monitoring systems (CGM) have revolutionized how hyperinsulinism is diagnosed and managed. These small devices are attached to the skin with a tiny sensor that sits just under the surface. The sensor measures glucose in the fluid between cells continuously, day and night, and sends readings to a display device or smartphone every few minutes.^[1]

CGM systems allow doctors and parents to see patterns that finger-stick testing might miss. They reveal how blood sugar responds to meals, medications, activity, and sleep. They also detect hypoglycemia that occurs during sleep, when a child cannot report symptoms. Alarms can be set to alert caregivers when blood sugar drops below a certain level, providing an early warning system that helps prevent severe episodes. For children whose hypoglycemia occurs unpredictably, CGM provides reassurance and safety that traditional testing cannot match.^[1]

While CGM has greatly improved hyperinsulinism care, it is important to understand that these devices are not perfectly accurate, especially when blood sugar is very low. Most portable glucose meters and CGM systems can be off by as much as 20 percent when measuring glucose below 70 mg/dL. For this reason, any CGM reading indicating low blood sugar should be confirmed with a laboratory test using blood drawn into a special tube containing sodium fluoride, which prevents the blood cells from consuming glucose before the sample is analyzed. Despite this limitation, CGM remains an invaluable tool for day-to-day management and helps reduce the frequency of painful finger sticks.^[6]

⚠️ Important

Hyperinsulinism requires care at specialized centers with experienced multidisciplinary teams. Only about 80 to 120 new cases occur each year in the United States, making it so rare that most children’s hospitals encounter only one or two cases annually. Centers specializing in hyperinsulinism have access to rapid genetic testing, PET-CT scanning, and surgical expertise that general hospitals may not possess.^[2]

Diagnostics for Clinical Trial Qualification

Children with hyperinsulinism may be eligible to participate in clinical trials testing new treatments. These research studies require standardized diagnostic criteria to ensure all participants truly have the condition and can be compared fairly. Understanding the testing required for clinical trial enrollment helps families prepare if they are considering this option.

Standard Diagnostic Criteria

Clinical trials for hyperinsulinism typically follow international diagnostic guidelines established by expert consensus. To qualify, patients must have documented hypoglycemia—usually defined as blood glucose below 60 mg/dL on multiple occasions—along with laboratory evidence of excessive insulin during those episodes. The critical blood sample obtained during hypoglycemia must show detectable insulin and C-peptide when these should be suppressed. Low ketone bodies and low free fatty acids at the time of hypoglycemia provide additional confirmation.^[10]

Most clinical trials require that hyperinsulinism be confirmed as the primary cause of hypoglycemia by excluding other possibilities. This means testing must rule out other conditions that can cause low blood sugar, such as cortisol deficiency, growth hormone deficiency, certain metabolic disorders, and medication effects. Comprehensive metabolic screening and hormone testing are typically performed to meet these requirements. Some trials accept only genetic forms of hyperinsulinism, requiring participants to have an identified mutation in one of the known disease-causing genes.^[10]

Imaging Requirements

Many clinical trials, particularly those testing new medications, require an 18F-DOPA PET-CT scan to classify the disease as focal or diffuse. This imaging must be performed at a certified center using standardized protocols to ensure quality and consistency. The scan results help researchers understand whether treatments work differently for focal versus diffuse disease and may be used to select which patients are most likely to benefit from a particular therapy. Trials focusing on surgical techniques may have even more specific imaging requirements, including detailed anatomical mapping of the pancreas.^[16]

Functional Testing

Clinical trials often require standardized fasting studies following specific protocols. These controlled tests measure how long a child can fast safely before developing hypoglycemia and how quickly blood sugar drops once feeding stops. The fasting study provides objective measurement of disease severity, which helps researchers determine if a treatment is working by comparing pre-treatment and post-treatment fasting tolerance. Some trials require multiple fasting studies over time to document changes in disease activity.^[10]

Medication trials may also require a glucose infusion rate test. This measures how much sugar must be given intravenously to keep blood glucose normal. Children with severe hyperinsulinism may require glucose infusion rates of 20-30 milligrams per kilogram per minute—three to four times higher than the body’s normal glucose production rate. Reduction in the glucose infusion rate needed to maintain normal blood sugar serves as an objective measure of treatment effectiveness in clinical trials.^[6]

Quality of Life and Development Assessments

Because preventing brain damage is the ultimate goal of hyperinsulinism treatment, many clinical trials include neurodevelopmental testing and quality of life assessments. Children may undergo cognitive testing, motor skills evaluation, and behavioral assessments at the beginning and end of the trial. Parents often complete questionnaires about their child’s development, daily functioning, and overall wellbeing. These measures help researchers understand whether new treatments not only control blood sugar but also result in better long-term outcomes for children living with hyperinsulinism.^[1]

Some research studies focus specifically on understanding the relationship between hypoglycemia exposure and brain injury. These trials may include specialized brain imaging such as MRI scans to look for subtle changes in brain structure or function. Electroencephalograms (EEG) to measure brain electrical activity might be performed, especially in children who have had seizures. While these tests are primarily research tools rather than standard clinical care, they contribute to better understanding of how to protect children’s brains from hypoglycemia-related damage.^[1]

Prognosis and Survival Rate

Prognosis

The outlook for children with hyperinsulinism depends heavily on how quickly the condition is diagnosed and how effectively blood sugar is controlled during the critical early months and years of life. When hyperinsulinism is recognized immediately after birth and treatment begins right away, most children can avoid brain injury and develop normally. Children who experience repeated or prolonged episodes of severe hypoglycemia before diagnosis face higher risk of permanent neurological complications including epilepsy, cerebral palsy, developmental delays, motor disabilities, and learning problems.^[7]

Different forms of hyperinsulinism have different outlooks. Children with focal disease who undergo successful surgery to remove the abnormal pancreatic tissue are typically cured completely. Their blood sugar returns to normal, they require no further treatment, and they develop just like any other child. In contrast, children with diffuse disease requiring medical management may need years of intensive treatment with medications and frequent feedings. Some eventually outgrow the condition—particularly those with the transient form related to birth stress—while others require lifelong management.^[8]

Long-term studies show that if hypoglycemia is well-controlled during infancy and early childhood, most children can develop a normal range of cognitive, emotional, and social skills. Clinical remission, where all medications can be stopped, occurs in some cases after several years of treatment. The average duration of medical treatment until remission is approximately 49 to 57 months, though this varies widely among individuals. Children treated with the medication diazoxide may experience remission after an average of 57 months, while those requiring other treatments follow different timelines.^[12]

Children who require near-total pancreatectomy—surgical removal of most of the pancreas—face different long-term challenges. While the surgery often eliminates dangerous hypoglycemia, it frequently causes diabetes because too little insulin-producing tissue remains. These children require insulin injections for life, similar to children with type 1 diabetes. Some children develop diabetes immediately after surgery, while others maintain normal blood sugar initially but develop diabetes months or years later as they grow and their remaining pancreatic tissue becomes insufficient.^[18]

The psychological and social prognosis for families living with hyperinsulinism is also important to consider. The condition creates significant stress due to the constant need for monitoring, frequent feedings even overnight, medication administration, and fear of hypoglycemic episodes. Access to specialized care centers, support groups, and family education greatly improves quality of life and helps families cope with the demands of managing this rare disease. Children treated at experienced centers with multidisciplinary teams generally have better outcomes than those managed at facilities with limited hyperinsulinism expertise.^[1]

Survival Rate

Hyperinsulinism itself is rarely fatal when properly diagnosed and treated. The primary risk to life comes from severe, prolonged hypoglycemia that is unrecognized or inadequately treated. Before modern understanding and management of hyperinsulinism, the condition could be fatal for infants whose blood sugar dropped so low that they stopped breathing or experienced cardiac arrest. Today, with prompt diagnosis and immediate intervention, death from hyperinsulinism is extremely uncommon in resource-rich settings with access to specialized pediatric care.^[4]

The more significant concern than mortality is morbidity—the long-term disability that can result from hypoglycemic brain injury. Historical data from before specialized hyperinsulinism centers existed showed that a substantial percentage of children survived but experienced permanent neurological damage. Modern data from specialized centers demonstrates dramatically better outcomes. When diagnosis occurs early—ideally within the first days or weeks of life—and blood sugar is maintained consistently above 60 mg/dL, the vast majority of children develop normally without lasting brain injury.^[7]

Approximately 60 percent of babies with congenital hyperinsulinism are diagnosed within their first month of life, 30 percent within their first year, and the remaining 10 percent sometime after that. Earlier diagnosis strongly correlates with better outcomes. The availability of prenatal genetic testing in families with a known history of hyperinsulinism has allowed some babies to be diagnosed even before birth, enabling immediate treatment from the moment of delivery and dramatically reducing the risk of any hypoglycemic episodes.^[4]

Long-term survival for children with well-managed hyperinsulinism is essentially normal. They grow into adults who can live full, productive lives, though some continue requiring medical management or diabetes care if they underwent pancreatectomy. The rare exception is when hyperinsulinism occurs as part of a complex genetic syndrome with other serious health problems, in which case the overall prognosis depends on all aspects of that syndrome rather than hyperinsulinism alone. For isolated hyperinsulinism—even severe forms—the outlook is generally excellent when expert care is available from the beginning.^[8]

#1 Clinical Trials Search in Europe

Hyperinsulinism – Diagnostics

Introduction: Who Should Be Tested and When